Home / News

News

Invectys, Inc. Appoints François Lescure as General Ma...

Invectys, Inc. Appoints François Lescure as General Manager of its R&D Subsidiary, Invectys, SAS Houston, Texas, USA – April 11, 2022 (GLOBE NEWSWIRE) –…

Read more

Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scienti...

Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scientific Advisory Board Houston, TX, USA, March 8, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston, Texas,…

Read more

Invectys appoints Jian Cao, Ph.D., as Vice President, P...

Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development Houston, TX, USA, March 1st, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston,…

Read more

Senior Research Associate (F/H) – Fixed-term contract...

Invectys is looking for a Senior Research Associate with expertise in Biotechnology/Immuno-Oncology to be part of our CAR-T Preclinical Development department based…

Read more

Research Associate (F/M) – Fixed-term contract 12 mon...

Invectys, a Biopharmaceutical Company developing Innovative Immunotherapy products for the treatment of cancers and disorders of the immune system is looking for…

Read more

Invectys to Provide 2022 Business Outlook at the H.C. W...

Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Houston, Texas, USA – January 6th, 2022 (GLOBE NEWSWIRE) –…

Read more

INVECTYS INC. TO PARTICIPATE IN THE 2022 JP MORGAN HEAL...

Houston, Texas, USA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development…

Read more

INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGH...

Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…

Read more